BridgeMD
Tests treatment safety and results for Lactation Disorders
Official title The Relationship Between Oxytocin Massage in Mothers With Insufficient Milk Production in the Early Postpartum Period and Breastfeeding Self-Efficacy and Milk Let-down Reflex: A Randomized Controlled Study
ClinicalTrials.gov ID: NCT07609693
What this study is testing
- What it's testing
- This randomized controlled trial aims to evaluate the effects of oxytocin massage on breastfeeding self-efficacy and the milk ejection reflex among mothers experiencing insufficient milk supply in the early postpartum period. Insufficient milk supply is a common issue often linked to maternal stress, which can inhibit oxytocin release and negatively impact the milk ejection reflex and the mother's confidence in breastfeeding.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Being 18 years of age or older
- Being in the early postpartum period (within the first 24-48 hours after birth)
- Having had a single, live birth via vaginal delivery or cesarean section
- Having a term (≥37 weeks) and healthy baby
- Being in the same room as the baby (rooming-in practice)
You likely can't join if
- Having given birth preterm (\<37 weeks)
- Having given birth as a result of a multiple pregnancy
- Having been admitted to the neonatal intensive care unit (NICU)
- The baby having a congenital anomaly that prevents breastfeeding (e.g., cleft lip and palate)
- The mother having medical conditions that contraindicate breastfeeding (HIV infection, active tuberculosis, etc.)
- The mother developing serious postpartum complications (postpartum hemorrhage, eclampsia, serious infection, etc.)
See the full eligibility criteria
- Being 18 years of age or older
- Being in the early postpartum period (within the first 24-48 hours after birth)
- Having had a single, live birth via vaginal delivery or cesarean section
- Having a term (≥37 weeks) and healthy baby
- Being in the same room as the baby (rooming-in practice)
- Having started breastfeeding
- Reporting insufficient milk production or expressing difficulty with the milk let-down reflex
- Not having a cognitive, neurological, or serious psychiatric problem that would impede communication
- Voluntary participation in the study and providing written informed consent
- Having given birth preterm (\<37 weeks)
- Having given birth as a result of a multiple pregnancy
- Having been admitted to the neonatal intensive care unit (NICU)
- The baby having a congenital anomaly that prevents breastfeeding (e.g., cleft lip and palate)
- The mother having medical conditions that contraindicate breastfeeding (HIV infection, active tuberculosis, etc.)
- The mother developing serious postpartum complications (postpartum hemorrhage, eclampsia, serious infection, etc.)
- The presence of anatomical or pathological conditions related to the breast that may prevent breastfeeding (advanced mastitis, breast abscess, etc.)
- The presence of skin lesions, surgical incisions, or infections in the back that would prevent the application of oxytocin massage
- Failure to complete the intervention or wishing to withdraw from the study will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Kahramanmaraş, Merkez, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kahramanmaraş, Merkez, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.